Why Kymera Therapeutics Stock Popped This Week: Key Moves
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Choose from credit cards with zero annual fees that offer cash back rewards. Keep all your rewards and maximize your savings.
23,592 articlesA flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Tesla delivered 480,126 vehicles in Q2 2026, topping estimates by 74,000 and signaling a rebound in EV demand. The fo...
As spacex insider lockups start, investors watch for how staged unlocks could affect liquidity and volatility. This a...
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
Dell's disciplined AI server strategy contrasts with Super Micro's margin challenges, underscoring two big server bet...
When a founder sells a portion of stock, investors often wonder if it signals trouble or opportunity. This deep dive ...
Nvidia is not just riding the AI wave—it's shaping it. This article explains why trillion reasons nvidia phenomenal, ...
Krispy Kreme’s stock jumped after a quarterly report showed potential signs of a turnaround, even as revenue declined...
A major fund just disclosed a sizable stake in Tango Therapeutics (TNGX), totaling about $9.5 million. This move shin...
Coinbase just delivered fantastic news for investors by expanding beyond crypto into stocks and ETFs. This article br...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
A headline-grabbing $60 million deal with Harry and Meghan raised questions about value, expectations, and how to mea...